Drugs
A federal appeals court ruling cleared the way for the sale of a generic version of Prozac, the world's top-selling antidepressant, as early as next summer. The ruling, which was in favor of Barr Laboratories, the company that will sell the first generic version of Prozac, is expected
Drugs
The Product Quality Research Institute (PQRI) is set to host a critical conference in September, where the first major dispute between FDA and the regulated industry over blend uniformity analysis (BUA) will take center stage. The August 1999 draft guidance on BUA has triggered concerns among industry stakeholders, who fear
Drugs
Abbott Labs, a well-established pharmaceutical firm, has once again drawn the attention of FDA investigators with a warning letter issued on July 3. This time, the scrutiny is focused on the company's North Chicago facility, where inspectors found issues with sterilizer filter validation studies and product testing procedures
Drugs
AVANIR Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted full marketing approval for docosanol 10% cream, a topical treatment for recurrent oral-facial herpes simplex infections, commonly known as cold sores or fever blisters. The first drug product of AVANIR Pharmaceuticals, docosanol 10% cream is also
Drugs
Pharmaceutical companies Pharmacia and Schering-Plough saw significant increases in their second-quarter profits, with Pharmacia's profit from operations rising 20 percent to $622 million, and Schering-Plough's net income increasing by 16 percent to $634 million. SmithKline Beecham's profit also rose, driven by strong demand for
Drugs
Immunex Corporation, a biopharmaceutical company, has reported net income of $41.5 million, or 8 cents per share, on total revenue of $213.2 million for the second quarter of 2000. This compares to net income of $6.9 million, or 1 cent per share, on revenues of $128.5
Drugs
Incyte Genomics, a leading genomic information company, and American Home Products, a major research-oriented pharmaceutical company, announced a partnership that grants AHP access to Incyte's suite of gene sequence databases, including LifeSeq(R) Gold, for use in drug discovery and development. This partnership highlights the significance of transcribed
Drugs
Researchers at the 13th International AIDS Conference announced a new approach to using AIDS drugs that could ease the treatment burden for patients. This approach, dubbed "stop-and-go," involves stopping AIDS drugs for short periods and then replenishing them before the virus has a chance to get out of
Drugs
Developing countries have long struggled with accessing AIDS drugs, but recent announcements by pharmaceutical companies and foundations have sparked a new wave of hope. The International AIDS Conference in Durban, South Africa, has seen numerous declarations from companies willing to reduce prices or provide drugs at a discount. However, health
Drugs
UK Chancellor Gordon Brown and Trade and Industry Secretary Stephen Byers will unveil a major initiative to boost scientific research in UK universities, in partnership with the Wellcome Trust, the world's richest charity. The two-year plan, worth £1bn, aims to equip laboratories, construct new buildings, and refurbish outdated
Drugs
The UK government, led by Chancellor Gordon Brown, is set to make a significant investment in science, pledging £1 billion in funding over the next three years. This move aims to reverse the brain drain, which has led to many of Britain's leading practitioners emigrating abroad due to
Drugs
Incyte Genomics and Eli Lilly have expanded their collaboration to accelerate the development of therapeutic proteins. The two companies will focus on the identification and selection of secreted molecules that are strong candidates for therapeutic protein development. Lilly will also obtain options to license multiple therapeutic protein patents from Incyte.
